An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

duloxetine

30mg oral duloxetine per day for one week, titrated up to 60mg per day at day 8, concluded by a one week taper period of 4 days of 30mg pills at the conclusion of the study, followed by 3 days on no medication (4+3 days=1 week), concluded with a post-taper follow-up appointment with a study physician.

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Mclean Hospital

OTHER

NCT00401258 - An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter